CTNM Contineum Therapeutics, Inc. - Common stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jul 30, 2026
$13.12
· of 52w range
· above low
· to high
$8.6052w low
$17.7952w high
P/E
-5.3
EPS
$-2.17
Revenue
$0
your badges
52W Range
$9–$18
Analyst Rating
STRONG BUY
Price Target
$22
P/E
-5.3
ROE
-27.7%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
CTNM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$13.12
P/E
-5.3
EPS
$-2.17
Revenue
$0
ROE
-27.7%
52W Range
$9–$18
CTNM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$02023-12-31 → 2024-12-31
EPS$-2.172023-12-31 → 2025-12-31
Free Cash Flow$-56M2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | CTNM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -5.3 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | CTNM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -24.5% | · | -23.5% | In line | |
| ROE | -27.7% | · | 18.3% | Weak | |
| ROIC | -26.1% | · | -26.1% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | CTNM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 37.2 | · | 6.2 | Strong liquidity | |
| Quick Ratio | 27.0 | · | 2.9 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | CTNM | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$0.00 | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-2.4%
Next Report
Oct 28, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-0.40 | $-0.46 | 13.2% |
| March 31, 2026 | May 14, 2026 | $-0.39 | $-0.54 | 28.1% |
| Dec. 31, 2025 | $-0.49 | $-0.41 | -18.4% | |
| Sept. 30, 2025 | $-0.45 | $-0.49 | 8.8% | |
| June 30, 2025 | $-0.62 | $-0.45 | -38.1% | |
| March 31, 2025 | $-0.62 | $-0.58 | -7.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | · | $0 | $50M | |
| R&D Expense | $52M | $38M | $28M | |
| SG&A Expense | $17M | $12M | $6M | |
| Operating Expenses | $68M | $51M | $34M | |
| Operating Income | $-68M | $-51M | $16M | |
| Interest Income | $8M | $9M | $5M | |
| Other Non-op | $-165.0K | $-163.0K | $-177.0K | |
| Pretax Income | $-60M | $-42M | $23M | |
| Income Tax | $0 | $0 | $450.0K | |
| Net Income | $-60M | $-42M | $23M | |
| EPS (Basic) | $-2.17 | $-2.18 | $1.36 | |
| EPS (Diluted) | $-2.17 | $-2.18 | $0.08 | |
| Shares (Basic) | 27,700,855 | 19,352,859 | 2,308,972 | |
| Shares (Diluted) | 27,700,855 | 19,352,859 | 3,395,514 | |
| EBITDA | $-68M | $-51M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $76M | $22M | $16M | |
| Short-term Investments | $187M | $183M | $110M | |
| Prepaid Expense | $5M | $2M | $3M | |
| Current Assets | $268M | $206M | $128M | |
| PP&E (Net) | $830.0K | $989.0K | $678.0K | |
| PP&E (Gross) | $3M | $3M | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | |
| Other Non-current Assets | $256.0K | $3.0K | $1M | |
| Total Assets | $277M | $213M | $130M | |
| Accounts Payable | $1M | $2M | $635.0K | |
| Accrued Liabilities | $6M | $7M | $4M | |
| Current Liabilities | $10M | $10M | $5M | |
| Capital Leases | $6M | $5M | $108.0K | |
| Other Non-current Liabilities | · | $0 | $110.0K | |
| Total Liabilities | $16M | $15M | $6M | |
| Common Stock | · | · | $2.0K | |
| Paid-in Capital | $438M | $315M | $7M | |
| Retained Earnings | $-177M | $-117M | $-75M | |
| AOCI | $260.0K | $71.0K | $108.0K | |
| Stockholders' Equity | $261M | $198M | $-68M | |
| Liabilities + Equity | $277M | $213M | $130M | |
| Shares Outstanding | · | · | 2,349,554 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $323.0K | $258.0K | $195.0K | |
| Stock-based Comp | $10M | $7M | $2M | |
| Other Non-cash | $-6M | $2M | · | |
| Operating Cash Flow | $-55M | $-33M | $19M | |
| CapEx | $231.0K | $514.0K | $414.0K | |
| Investing Cash Flow | $-4M | $-70M | $-66M | |
| Net Debt Issued | · | $0 | · | |
| Stock Issued | · | $108M | $0 | |
| Net Stock Activity | · | $108M | · | |
| Financing Cash Flow | $113M | $109M | $56M | |
| Net Change in Cash | $54M | $6M | $10M | |
| Taxes Paid | $1.0K | $1.0K | $450.0K | |
| Free Cash Flow | $-56M | $-33M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -24.5% | -24.6% | · | |
| ROE | -27.7% | -20.7% | · | |
| ROIC | -26.1% | -25.7% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 27.5 | 20.7 | · | |
| Quick Ratio | 27.0 | 20.5 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue / Share | · | $0.00 | · | |
| Cash Flow / Share | $-2.00 | $-1.70 | · | |
| EPS (TTM) | $-2.17 | $-2.18 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | · | $0 | · | |
| Net Income TTM | $-60M | $-42M | · | |
| P/E | -5.3 | -6.7 | · | |
| Earnings Yield | -19.0% | -14.9% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $0 | $50M | |
| R&D Expense | $13M | $12M | $13M | $11M | $14M | $14M | $13M | $10M | $8M | $8M | $8M | $6M | $9M | |
| SG&A Expense | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $17M | $17M | $17M | $15M | $18M | $18M | $17M | $13M | $11M | $10M | $10M | $8M | $11M | |
| Operating Income | $-17M | $-17M | $-17M | $-15M | $-18M | $-18M | $-17M | $-13M | $-11M | $-10M | $-10M | $-8M | $39M | |
| Interest Income | $2M | $3M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $679.0K | |
| Other Non-op | $-68.0K | $-57.0K | $-51.0K | $183.0K | $-167.0K | $-130.0K | $-46.0K | $-34.0K | $-77.0K | $-6.0K | $-47.0K | $-36.0K | $-76.0K | |
| Pretax Income | · | · | · | · | · | · | $-15M | $-10M | $-9M | $-8M | $-8M | $-6M | $42M | |
| Income Tax | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-161.0K | $-118.0K | $729.0K | |
| Net Income | $-15M | $-14M | $-15M | $-13M | $-16M | $-16M | $-15M | $-10M | $-9M | $-8M | $-8M | $-6M | $42M | |
| EPS (Basic) | $-0.40 | $-0.39 | $-0.48 | $-0.45 | $-0.62 | $-0.62 | $2.16 | $-0.40 | $-0.39 | $-3.55 | $3.61 | $-2.69 | $2.56 | |
| EPS (Diluted) | $-0.40 | $-0.39 | · | · | $-0.62 | $-0.62 | $-0.57 | $-0.40 | $-0.39 | · | $-0.35 | $-2.69 | $0.84 | |
| Shares (Basic) | 37,467,840 | 37,339,026 | · | 28,115,548 | 25,895,996 | 25,868,935 | · | 25,730,014 | 23,355,588 | 2,369,067 | · | 2,324,588 | 2,291,866 | |
| Shares (Diluted) | 37,467,840 | 37,339,026 | · | · | 25,895,996 | 25,868,935 | · | 25,730,014 | 23,355,588 | 2,369,067 | · | 2,324,588 | 3,511,757 | |
| EBITDA | $-17M | $-17M | · | $-15M | $-18M | $-18M | · | $-13M | $-11M | $-10M | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $20M | $76M | $43M | $21M | $22M | $22M | $41M | $77M | $16M | $16M | · | · | |
| Short-term Investments | $222M | $226M | $187M | $140M | $155M | $168M | $183M | $173M | $141M | $102M | $110M | · | · | |
| Prepaid Expense | $6M | $7M | $5M | $3M | $1M | $1M | $2M | $1M | $2M | $2M | $3M | · | · | |
| Current Assets | $243M | $253M | $268M | $185M | $177M | $192M | $206M | $215M | $220M | $120M | $128M | · | · | |
| PP&E (Net) | $929.0K | $1M | $830.0K | $880.0K | $856.0K | $891.0K | $989.0K | $888.0K | $801.0K | $756.0K | $678.0K | · | · | |
| PP&E (Gross) | · | · | $3M | · | · | · | $3M | · | · | · | $2M | · | · | |
| Accum. Depreciation | · | · | $2M | · | · | · | $2M | · | · | · | $1M | · | · | |
| Other Non-current Assets | $364.0K | $312.0K | $256.0K | $266.0K | $186.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3M | $1M | · | · | |
| Total Assets | $250M | $261M | $277M | $191M | $183M | $198M | $213M | $216M | $221M | $124M | $130M | · | · | |
| Accounts Payable | $505.0K | $1M | $1M | $786.0K | $2M | $4M | $2M | $1M | $734.0K | $570.0K | $635.0K | · | · | |
| Accrued Liabilities | $4M | $3M | $6M | $4M | $4M | $4M | $7M | $4M | $3M | $5M | $4M | · | · | |
| Current Liabilities | $7M | $7M | $10M | $6M | $7M | $9M | $10M | $6M | $4M | $6M | $5M | · | · | |
| Capital Leases | $4M | $5M | $6M | $4M | $4M | $5M | $5M | $0 | $113.0K | $111.0K | $108.0K | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $0 | $0 | $228.0K | $110.0K | · | · | |
| Total Liabilities | $11M | $11M | $16M | $10M | $11M | $13M | $15M | $6M | $4M | $7M | $6M | · | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | $2.0K | · | · | · | |
| Paid-in Capital | $447M | $442M | $438M | $342M | $321M | $318M | $315M | $312M | $310M | $8M | $7M | · | · | |
| Retained Earnings | $-207M | $-192M | $-177M | $-162M | $-149M | $-133M | $-117M | $-103M | $-93M | $-84M | $-75M | · | · | |
| AOCI | $-573.0K | $-253.0K | $260.0K | $265.0K | $147.0K | $170.0K | $71.0K | $561.0K | $-127.0K | $-58.0K | $108.0K | · | · | |
| Stockholders' Equity | $240M | $250M | $261M | $180M | $171M | $185M | $198M | $210M | $218M | $-76M | $-68M | · | · | |
| Liabilities + Equity | $250M | $261M | $277M | $191M | $183M | $198M | $213M | $216M | $221M | $124M | $130M | · | · | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | 2,384,426 | · | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $134.0K | $83.0K | $85.0K | $81.0K | $79.0K | $78.0K | $75.0K | $62.0K | $60.0K | $61.0K | $37.0K | $43.0K | $42.0K | |
| Stock-based Comp | $4M | $4M | $2M | $3M | $2M | $3M | $2M | $2M | $1M | $768.0K | $759.0K | $477.0K | $489.0K | |
| Other Non-cash | · | $-6M | · | · | · | $-1M | · | · | · | $-387.0K | · | · | · | |
| Operating Cash Flow | $-12M | $-16M | $-13M | $-12M | $-16M | $-14M | $-10M | $-6M | $-8M | $-8M | $-11M | $-5M | $41M | |
| CapEx | $6.0K | $312.0K | $42.0K | $98.0K | $44.0K | $47.0K | $166.0K | $82.0K | $119.0K | $147.0K | $309.0K | $22.0K | $31.0K | |
| Investing Cash Flow | $5M | $-39M | $-47M | $15M | $14M | $15M | $-9M | $-30M | $-39M | $9M | $9M | $-39M | $-44M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | |
| Financing Cash Flow | $1M | $129.0K | $93M | $19M | $91.0K | $24.0K | $642.0K | $13.0K | $108M | $-18.0K | $-321.0K | $10M | $47M | |
| Net Change in Cash | $-5M | $-55M | $33M | $22M | $-2M | $527.0K | $-19M | $-36M | $61M | $738.0K | $-2M | $-35M | $43M | |
| Free Cash Flow | · | $-17M | · | · | · | $-14M | · | · | · | $-8M | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -7.0% | -6.3% | · | -6.3% | -7.9% | -9.9% | · | -9.5% | -8.1% | -13.6% | · | · | · | |
| ROE | -7.4% | -6.7% | · | -6.6% | -8.2% | -29.3% | · | -9.8% | -8.3% | 22.3% | · | · | · | |
| ROIC | · | · | · | · | · | · | · | -6.2% | -5.0% | 13.1% | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 37.2 | 38.0 | · | 29.1 | 24.5 | 21.5 | · | 37.1 | 58.9 | 19.2 | · | · | · | |
| Quick Ratio | 36.2 | 37.0 | · | 28.7 | 24.3 | 21.3 | · | 36.8 | 58.5 | 18.9 | · | · | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.0 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | · | · | · | $-31.72 | · | · | · | |
| Revenue / Share | · | · | · | · | · | · | · | $0.00 | $0.00 | · | · | · | · | |
| Cash Flow / Share | · | $-0.44 | · | · | · | · | · | · | · | $-3.37 | · | · | · | |
| Cash / Share | · | · | · | · | · | · | · | · | · | $6.82 | · | · | · | |
| EPS (TTM) | · | · | · | $-2.21 | $-2.21 | $-1.98 | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-58M | $-58M | · | $-59M | $-57M | $-50M | · | $-35M | $-31M | $19M | · | · | · | |
| P/E | · | · | · | -5.3 | -1.8 | -3.5 | · | · | · | · | · | · | · | |
| Earnings Yield | · | · | · | -18.8% | -55.7% | -28.4% | · | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | · | $0 | $50M |
| Net Income | $-60M | $-42M | $23M |
| Diluted EPS | $-2.17 | $-2.18 | $0.08 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Current Ratio | 27.5 | 20.7 | · |
| Quick Ratio | 27.0 | 20.5 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | $-56M | $-33M | · |
Institutional owners (13F) 107 filers · $505.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
107
Value held
$505.6M
New positions
28
Exited positions
15
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 28 (+5 vs prior Q) | 15 (+4 vs prior Q) | 33 (+3 vs prior Q) | 19 (-1 vs prior Q) | -2.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $46,569,464 | 2,841,334 | 9.21% | Shares |
| JANUS HENDERSON GROUP PLC | $35,593,891 | 2,734,836 | 7.04% | Shares |
| BlackRock, Inc. | $33,834,614 | 2,064,345 | 6.69% | Shares |
| JOHNSON & JOHNSON | $32,438,645 | 1,979,173 | 6.42% | Shares |
| FRANKLIN RESOURCES INC | $30,144,931 | 1,839,227 | 5.96% | Shares |
| Balyasny Asset Management L.P. | $24,958,577 | 1,522,793 | 4.94% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $21,657,025 | 1,321,356 | 4.28% | Shares |
| PERCEPTIVE ADVISORS LLC | $20,579,153 | 1,255,592 | 4.07% | Shares |
| FMR LLC | $17,047,731 | 1,040,130 | 3.37% | Shares |
| MILLENNIUM MANAGEMENT LLC | $15,270,711 | 931,709 | 3.02% | Shares |
| GREAT POINT PARTNERS LLC | $15,103,074 | 921,481 | 2.99% | Shares |
| VANGUARD GROUP INC | $14,525,907 | 1,270,858 | 2.87% | Shares |
| Longaeva Partners L.P. | $13,321,087 | 812,757 | 2.63% | Shares |
| Ikarian Capital, LLC | $13,241,056 | 807,874 | 2.62% | Shares |
| SECTORAL ASSET MANAGEMENT INC | $11,925,151 | 727,587 | 2.36% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $11,364,044 | 693,188 | 2.25% | Shares |
| HHLR ADVISORS, LTD. | $10,970,433 | 669,337 | 2.17% | Shares |
| RED TREE MANAGEMENT, LLC | $10,459,410 | 638,158 | 2.07% | Shares |
| Versant Venture Management, LLC | $8,893,673 | 542,628 | 1.76% | Shares |
| GOLDMAN SACHS GROUP INC | $8,150,009 | 497,255 | 1.61% | Shares |
| Boxer Capital Management, LLC | $8,096,660 | 494,000 | 1.60% | Shares |
| STATE STREET CORP | $6,980,534 | 425,902 | 1.38% | Shares |
| CITADEL ADVISORS LLC | $6,496,242 | 396,354 | 1.28% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $5,375,920 | 328,000 | 1.06% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $4,853,653 | 296,135 | 0.96% | Shares |
| ADAR1 Capital Management, LLC | $4,572,171 | 278,961 | 0.90% | Shares |
| NORTHERN TRUST CORP | $4,553,208 | 277,804 | 0.90% | Shares |
| Squadron Capital Management LLC | $4,261,400 | 260,000 | 0.84% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $3,643,972 | 222,329 | 0.72% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3,508,804 | 214,082 | 0.69% | Shares |
| Ishara Investments LP | $3,359,950 | 205,000 | 0.66% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $3,007,155 | 183,475 | 0.59% | Shares |
| Qube Research & Technologies Ltd | $2,989,749 | 182,413 | 0.59% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,955,150 | 180,302 | 0.58% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $2,925,440 | 178,673 | 0.58% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,905,636 | 177,281 | 0.57% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $2,471,563 | 150,797 | 0.49% | Shares |
| Casdin Capital, LLC | $2,431,178 | 148,333 | 0.48% | Shares |
| Eversept Partners, LP | $2,425,999 | 148,017 | 0.48% | Shares |
| UBS Group AG | $2,141,223 | 130,642 | 0.42% | Shares |
| DIADEMA PARTNERS LP | $1,962,424 | 119,733 | 0.39% | Shares |
| MARSHALL WACE, LLP | $1,934,971 | 118,058 | 0.38% | Shares |
| Trexquant Investment LP | $1,450,171 | 88,479 | 0.29% | Shares |
| Verdad Advisers, LP | $1,327,819 | 81,014 | 0.26% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $1,293,499 | 78,920 | 0.26% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,238,412 | 75,559 | 0.24% | Shares |
| Schonfeld Strategic Advisors LLC | $1,138,137 | 69,441 | 0.23% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,103,047 | 67,300 | 0.22% | Shares |
| Bank of New York Mellon Corp | $1,075,249 | 65,604 | 0.21% | Shares |
| ACUTA CAPITAL PARTNERS, LLC | $1,034,127 | 63,095 | 0.20% | Shares |
Company insiders 13 insiders · 6 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Carmine N. Stengone | CEO and President | Sept. 8, 2026 M | 17,217 | 0 | 7 | $-401,417 |
| Peter T Slover | Chief Financial Officer | Jan. 30, 2026 A | · | 0 | 0 | $0 |
| Daniel S. Lorrain | Chief Scientific Officer | July 9, 2026 M | 135,202 | 0 | 19 | $-1,134,493 |
| Tim Watkins | CMO & Head of Development | June 30, 2026 M | 8,961 | 0 | 5 | $-322,526 |
| John Stephen Healy | General Counsel and Corp Sec | Jan. 30, 2026 A | · | 0 | 0 | $0 |
| Stephen L. Huhn | CMO & Sr VP, Clinical Dev. | Jan. 31, 2025 A | 12,800 | 0 | 0 | $0 |
| Gines Diego Miralles | Director | June 26, 2026 A | · | 0 | 0 | $0 |
| Todd R. Brady | Director | June 26, 2026 A | · | 0 | 0 | $0 |
| Evert B. Schimmelpennink | Director | June 26, 2026 A | · | 0 | 0 | $0 |
| Lori Lyons-Williams | Director | June 26, 2026 A | · | 0 | 0 | $0 |
| Olivia C Ware | Director | June 26, 2026 A | · | 0 | 0 | $0 |
| Sarah Boyce | Director | June 26, 2026 A | · | 0 | 0 | $0 |
| Troy A. Ignelzi | Director | June 26, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 17 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.09% | 90,712 SH | Sept. 11, 2026 | Daily |
| IBB · iShares Trust | 0.03% | 224,957 SH | Sept. 11, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 23,368 SH | Aug. 19, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.03% | 2,344 SH | Oct. 2, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 12,794 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 678,495 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 154,662 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 54,517 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 800 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 2,968 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 4,445 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 1,428 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 1,762 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 308,647 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 982,259 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 2,272 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 253,552 SH | Sept. 11, 2026 | Daily |
CTNM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 14 analysts
BUY
Median target
$22.00
+67.7%
6 42.9%
Strong Buy
6 42.9%
Buy
2 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
7 analysts · 2026-10-04Mean target $22.43 +70.9%
← Below all targets
Current price $13.12
Low$17.00
Mean$22.43
High$28.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CTNM | · | -5.3 | · | · | -27.7% | · |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | · |
| ZVRA | $509M | 6.6 | 350.9% | 78.2% | 61.2% | · |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
| PHAT | $1.18B | -5.5 | 216.9% | -126.4% | 52.4% | 87.1% |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | · |
| ARVN | $753M | -10.4 | -0.30% | -30.8% | -15.5% | · |
| EOLS | $432M | -8.3 | 11.6% | -17.4% | 247.3% | 66.3% |
| AVIR | $279M | -1.8 | · | · | -49.5% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jul 30, 2026